Rapid Theraptic Scince Lab Stock Price, News & Analysis
Company Description
Rapid Theraptic Scince Lab (OTC Link: RTSL) is a publicly traded shell companies company in the Financial Services sector. The company has a market capitalization of $57.0K.
RTSL stock has gained 50.0% over the past year. Shares last traded at $0.0060.
On a trailing twelve-month basis, Rapid Theraptic Scince Lab reported revenue of $0 with net income of -$1.8M.
This page provides a comprehensive overview of RTSL stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Rapid Theraptic Scince Lab (RTSL) stock last traded at $0.0060. Over the past 12 months, the stock has gained 50.0%. At a market capitalization of $57.0K, RTSL is classified as a micro-cap stock with approximately 19.0M shares outstanding.
Latest News
Rapid Theraptic Scince Lab has 10 recent news articles. Of the recent coverage, 3 articles coincided with positive price movement and 4 with negative movement. Key topics include conferences, stock split. View all RTSL news →
SEC Filings
Financial Highlights
net income was -$1.8M. The company generated -$1.2M in operating cash flow. With a current ratio of 0.05, short-term liquidity bears monitoring.
Upcoming Events
Short Interest History
Days to Cover History
RTSL Company Profile & Sector Positioning
Rapid Theraptic Scince Lab (RTSL) operates in the Shell Companies industry within the broader Financial Services sector and is listed on the OTC Link.
Investors comparing RTSL often look at related companies in the same sector, including Better For You Wellness Inc (BFYW), DRAZCANNA INC (DZCA), Monkey Rock Group Inc (MKRO), Fccc Inc (FCIC), and Transatlantic (TACI). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate RTSL's relative position within its industry.